Abstract
Bupleurum falcatum (Umbelliferae) have been widely used to treat inflammatory diseases as traditional medicines in East Asian region. Although saikosaponins are main bioactive molecules of B. falcatum, there is little information on bioactivity of saikosaponin B2 (SSB2). This study was conducted to assess the anti-inflammatory activities and the involved mechanisms of SSB2 in LPS-induced RAW 264.7 macrophages. SSB2 suppressed the releases of nitric oxide (NO), prostaglandin E2 (PGE2), tumor necrosis factor α (TNF-α), interleukins (IL)-6, and IL-1β by suppressing mRNA levels of inducible NO synthase (iNOS), cyclooxygenase-2 (COX-2), TNF-α, IL-1β, and IL-6 in LPS-induced macrophages. SSB2 blocked LPS-induced DNA binding and nuclear factor kappa B (NF-κB) transcriptional activity by inhibiting nuclear translocation p65 and p50, inhibitory κBα (IκBα) degradation, and IκB kinase β (IKKβ) phosphorylation and activity. In IKKβ-overexpressing cells, SSB2 significantly suppressed IKKβ-dependent NF-κB transcriptional activity. Moreover, SSB2 reduced phosphorylation of p38 and extracellular signal-regulated kinase1/2 (ERK1/2). SSB2 effectively inhibits LPS-induced pro-inflammatory mediator releases by interfering with IKKβ and IκBα activation, thus preventing NF-κB activation. Our data indicates that SSB2 could be a potential therapeutic application for inflammation-associated diseases.
Similar content being viewed by others
References
Adhikari, A., M. Xu, and Z.J. Chen. 2007. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26 (22): 3214–3226.
Berghaus, L.J., J.N. Moore, D.J. Hurley, M.L. Vandenplas, B.P. Fortes, M.A. Wolfert, and G.J. Boons. 2010. Innate immune responses of primary murine macrophage-lineage cells and RAW 264.7 cells to ligands of toll-like receptors 2, 3, and 4. Comparative Immunology, Microbiology and Infectious Diseases 33 (5): 443–454.
Bhatt, D., and S. Ghosh. 2014. Regulation of the NF-kappaB-mediated transcription of inflammatory genes. Frontiers in Immunology 5: 71.
Chen, B.C., and W.W. Lin. 2001. PKC- and ERK-dependent activation of I kappa B kinase by lipopolysaccharide in macrophages: enhancement by P2Y receptor-mediated CaMK activation. British Journal of Pharmacology 134 (5): 1055–1065.
Chen, J., M. Duan, Y. Zhao, F. Ling, K. Xiao, Q. Li, B. Li, et al. 2015. Saikosaponin A inhibits influenza A virus replication and lung immunopathology. Oncotarget 6 (40): 42541–42556.
Chen, B., J. Liu, T.T. Ho, X. Ding, and Y.Y. Mo. 2016. ERK-mediated NF-kappaB activation through ASIC1 in response to acidosis. Oncogenesis 5 (12): e279.
Chen, M.F., S.J. Huang, C.C. Huang, P.S. Liu, K.I. Lin, C.W. Liu, W.C. Hsieh, L.Y. Shiu, and C.H. Chen. 2016. Saikosaponin d induces cell death through caspase-3-dependent, caspase-3-independent and mitochondrial pathways in mammalian hepatic stellate cells. BMC Cancer 16: 532.
Cheng, P., T. Wang, W. Li, I. Muhammad, H. Wang, X. Sun, Y. Yang, J. Li, T. Xiao, and X. Zhang. 2017. Baicalin alleviates lipopolysaccharide-induced liver inflammation in chicken by suppressing TLR4-mediated NF-kappaB pathway. Frontiers in Pharmacology 8: 547.
Christiaens, I., D.B. Zaragoza, L. Guilbert, S.A. Robertson, B.F. Mitchell, and D.M. Olson. 2008. Inflammatory processes in preterm and term parturition. Journal of Reproductive Immunology 79 (1): 50–57.
Christian, F., E.L. Smith, and R.J. Carmody. 2016. The regulation of NF-kappaB subunits by phosphorylation. Cells 5 (1).
Craig, R., A. Larkin, A.M. Mingo, D.J. Thuerauf, C. Andrews, P.M. McDonough, and C.C. Glembotski. 2000. p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. The Journal of Biological Chemistry 275 (31): 23814–23824.
Dong, Z.W., J. Chen, Y.C. Ruan, T. Zhou, Y. Chen, L.L. Tsang, H.C. Chan, and Y.Z. Peng. 2015. CFTR-regulated MAPK/NF-kappaB signaling in pulmonary inflammation in thermal inhalation injury. Scientific Reports 5: 15946.
Doyle, S.L., and L.A. O'Neill. 2006. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochemical Pharmacology 72 (9): 1102–1113.
Ghosh, S., and M. Karin. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109 (Suppl): S81–S96.
Karin, M. 2005. Inflammation-activated protein kinases as targets for drug development. Proceedings of the American Thoracic Society 2 (4): 386–390 discussion 394-385.
Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annual Review of Immunology 18: 621–663.
Kawasaki, T., and T. Kawai. 2014. Toll-like receptor signaling pathways. Frontiers in Immunology 5: 461.
Kefaloyianni, E., C. Gaitanaki, and I. Beis. 2006. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cellular Signalling 18 (12): 2238–2251.
Kim, H.G., B. Shrestha, S.Y. Lim, D.H. Yoon, W.C. Chang, D.J. Shin, S.K. Han, S.M. Park, J.H. Park, H.I. Park, J.M. Sung, Y. Jang, N. Chung, K.C. Hwang, and T.W. Kim. 2006. Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells. European Journal of Pharmacology 545 (2–3): 192–199.
Kim, J.Y., S.J. Park, K.J. Yun, Y.W. Cho, H.J. Park, and K.T. Lee. 2008. Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages. European Journal of Pharmacology 584 (1): 175–184.
Kim, S.H., T.H. Lee, S.M. Lee, J.H. Park, K.H. Park, M. Jung, H. Jung, M.A.A. Mohamed, N.I. Baek, I.S. Chung, and J. Kim. 2015. Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators via MAPK inhibition and NF-kappaB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock. Experimental Biology and Medicine 240 (7): 946–954.
Kim, S.O., J.Y. Park, S.Y. Jeon, C.H. Yang, and M.R. Kim. 2015. Saikosaponin a, an active compound of Radix Bupleuri, attenuates inflammation in hypertrophied 3T3-L1 adipocytes via ERK/NF-kappaB signaling pathways. International Journal of Molecular Medicine 35 (4): 1126–1132.
Lee, K.G., S.G. Lee, H.H. Lee, H.J. Lee, J.S. Shin, N.J. Kim, H.J. An, J.H. Nam, D.S. Jang, and K.T. Lee. 2015. Alpha-Chaconine isolated from a Solanum tuberosum L. cv Jayoung suppresses lipopolysaccharide-induced pro-inflammatory mediators via AP-1 inactivation in RAW 264.7 macrophages and protects mice from endotoxin shock. Chemico-Biological Interactions 235: 85–94.
Lee, W.S., J.S. Shin, D.S. Jang, and K.T. Lee. 2016. Cnidilide, an alkylphthalide isolated from the roots of Cnidium officinale, suppresses LPS-induced NO, PGE2, IL-1beta, IL-6 and TNF-alpha production by AP-1 and NF-kappaB inactivation in RAW 264.7 macrophages. International Immunopharmacology 40: 146–155.
Li, M., M. Zhang, Z.L. Zhang, N. Liu, X.Y. Han, Q.C. Liu, W.J. Deng, and C.X. Liao. 2017. Induction of apoptosis by berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-kappaB. Oncology Research 25 (2): 233–239.
Lin, L.T., C.Y. Chung, W.C. Hsu, S.P. Chang, T.C. Hung, J. Shields, R.S. Russell, C.C. Lin, C.F. Li, M.H. Yen, D.L.J. Tyrrell, C.C. Lin, and C.D. Richardson. 2015. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. Journal of Hepatology 62 (3): 541–548.
Lu, C.N., Z.G. Yuan, X.L. Zhang, R. Yan, Y.Q. Zhao, M. Liao, and J.X. Chen. 2012. Saikosaponin a and its epimer saikosaponin d exhibit anti-inflammatory activity by suppressing activation of NF-kappaB signaling pathway. International Immunopharmacology 14 (1): 121–126.
Lu, X.L., S.X. He, M.D. Ren, Y.L. Wang, Y.X. Zhang, and E.Q. Liu. 2012. Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: involvement of CCAAT/enhancer binding protein beta and cyclooxygenase-2. Molecular Medicine Reports 5 (3): 637–644.
Ma, X., C. Dang, H. Kang, Z. Dai, S. Lin, H. Guan, X. Liu, X. Wang, and W. Hui. 2015. Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-kappaB signalling pathways. International Immunopharmacology 28 (1): 399–408.
Ma, H., S. Yokoyama, I. Saiki, and Y. Hayakawa. 2017. Chemosensitizing effect of Saikosaponin B on B16F10 melanoma cells. Nutrition and Cancer 69 (3): 505–511.
Moncada, S., R.M. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43 (2): 109–142.
Murakami, M., and I. Kudo. 2004. Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway. Progress in Lipid Research 43 (1): 3–35.
Scholich, K., and G. Geisslinger. 2006. Is mPGES-1 a promising target for pain therapy? Trends in Pharmacological Sciences 27 (8): 399–401.
Shin, J.S., Y.M. Park, J.H. Choi, H.J. Park, M.C. Shin, Y.S. Lee, and K.T. Lee. 2010. Sulfuretin isolated from heartwood of Rhus verniciflua inhibits LPS-induced inducible nitric oxide synthase, cyclooxygenase-2, and pro-inflammatory cytokines expression via the down-regulation of NF-kappaB in RAW 264.7 murine macrophage cells. International Immunopharmacology 10 (8): 943–950.
Shin, J.S., S.R. Baek, S.I. Sohn, Y.W. Cho, and K.T. Lee. 2011. Anti-inflammatory effect of pelubiprofen, 2-[4-(oxocyclohexylidenemethyl)-phenyl]propionic acid, mediated by dual suppression of COX activity and LPS-induced inflammatory gene expression via NF-kappaB inactivation. Journal of Cellular Biochemistry 112 (12): 3594–3603.
Shin, J.S., Y.S. Noh, Y.S. Lee, Y.W. Cho, N.I. Baek, M.S. Choi, T.S. Jeong, E. Kang, H.G. Chung, and K.T. Lee. 2011. Arvelexin from Brassica rapa suppresses NF-kappaB-regulated pro-inflammatory gene expression by inhibiting activation of IkappaB kinase. British Journal of Pharmacology 164 (1): 145–158.
Taciak, B., M. Bialasek, A. Braniewska, Z. Sas, P. Sawicka, L. Kiraga, T. Rygiel, and M. Krol. 2018. Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages. PLoS One 13 (6): e0198943.
Ushio, Y., and H. Abe. 1991. The effects of saikosaponin on macrophage functions and lymphocyte proliferation. Planta Medica 57 (6): 511–514.
Vermeulen, L., G. De Wilde, P. Van Damme, W. Vanden Berghe, and G. Haegeman. 2003. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). The EMBO Journal 22 (6): 1313–1324.
Wei, H.Y., and X. Ma. 2014. Tamoxifen reduces infiltration of inflammatory cells, apoptosis and inhibits IKK/NF-kB pathway after spinal cord injury in rats. Neurological Sciences 35 (11): 1763–1768.
Wei, Z., J. Wang, M. Shi, W. Liu, Z. Yang, and Y. Fu. 2016. Saikosaponin a inhibits LPS-induced inflammatory response by inducing liver X receptor alpha activation in primary mouse macrophages. Oncotarget 7 (31): 48995–49007.
Yamada, H., X.B. Sun, T. Matsumoto, K.S. Ra, M. Hirano, and H. Kiyohara. 1991. Purification of anti-ulcer polysaccharides from the roots of Bupleurum falcatum. Planta Medica 57 (6): 555–559.
Yamamoto, Y., and R.B. Gaynor. 2001. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. The Journal of Clinical Investigation 107 (2): 135–142.
Yang, J., Y. Cao, Z. Lv, T. Jiang, L. Wang, and Z. Li. 2015. Cordycepin protected against the TNF-alpha-induced inhibition of osteogenic differentiation of human adipose-derived mesenchymal stem cells. International Journal of Immunopathology and Pharmacology 28 (3): 296–307.
Yoo, M.S., J.S. Shin, H.E. Choi, Y.W. Cho, M.H. Bang, N.I. Baek, and K.T. Lee. 2012. Fucosterol isolated from Undaria pinnatifida inhibits lipopolysaccharide-induced production of nitric oxide and pro-inflammatory cytokines via the inactivation of nuclear factor-kappaB and p38 mitogen-activated protein kinase in RAW264.7 macrophages. Food Chemistry 135 (3): 967–975.
Funding
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2017R1A5A2014768) and supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2017R1A6A3A11031647).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All data generated or analyzed during this study are included in this published article. The data and materials were available to the corresponding author.
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Shin, JS., Im, HT. & Lee, KT. Saikosaponin B2 Suppresses Inflammatory Responses Through IKK/IκBα/NF-κB Signaling Inactivation in LPS-Induced RAW 264.7 Macrophages. Inflammation 42, 342–353 (2019). https://doi.org/10.1007/s10753-018-0898-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-018-0898-0